The Mayo Clinic-Canadian cooperative trial of sulfasalazine in active multiple sclerosis
John H. Noseworthy(Mayo Clinic), Elizabeth A. Shuster(Kaiser Permanente Center for Health Research), Alan Kirk(University of Michigan), Jackson P. Carter(Mayo Clinic), Brandon J. Erickson(Rothman Orthopaedics), George C. Ebers(John Radcliffe Hospital), Anthony Auty(Mayo Clinic), Pierre Duquette(Centre Hospitalier de l’Université de Montréal), Walter Hader(Western University), D. Sneve(Mayo Clinic), Daniel Lee(Mayo Clinic), Peter C. O’Brien(University Hospital Crosshouse), L Metz(Mayo Clinic), G. Francis(St. Michael's Hospital), G Rice
Cited by 95
Related Papers
Multiple Sclerosis
|New England Journal of Medicine|2000|2.9k
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
|The Lancet|1998|2.1k
The clinical course of neuromyelitis optica (Devic’s syndrome)
|Neurology|1999|1.8k
Executive Leadership and Physician Well-being
|Mayo Clinic Proceedings|2016|1.7k